Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 1, 2000, Pages 309-316

  Falorni, Alberto ^a,b   Gambelunghe, Giovanni ^a   Forini, Francesca ^a   Kassi, Georgia ^a   Cosentino, Anna ^a   Candeloro, Paola ^a   Bolli, Geremia B ^a   Brunetti, Paolo ^a   Calcinaro, Filippo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Department of Internal Medicine and Endocrine and Metabolic Sciences ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CARBOXY TERMINAL SEQUENCE; FEMALE; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; AGED; AUTOANTIBODIES; BIOLOGICAL MARKERS; C-PEPTIDE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; EPITOPES; FEMALE; FOLLOW-UP STUDIES; GLUTAMATE DECARBOXYLASE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; IODIDE PEROXIDASE; ISOENZYMES; ITALY; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 0034457410     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.1.309     Document Type: Article

References (45)

1. Immunology of insulin-dependent diabetes mellitus
2. Insulin antibodies in insulin-dependent diabetics before insulin treatment
3. Glutamic acid decarboxylase (GAD) in insulin-dependent diabetes mellitus
4. Tyrosine phosphatase-like proteins as autoantigens in insulin-dependent diabetes mellitus: The targets for 37/40k antibodies
5. Islet cell autoantigens in insulin-dependent diabetes
6. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
7. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
8. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in β cells
9. Concentration of insulin autoantibodies at onset of type I diabetes: Inverse log-linear correlation with age
10. Immunological heterogeneity in type I diabetes: Presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease
11. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years
12. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type
13. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease
14. Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of Type I diabetes
15. Immunogenetic and clinical characterization of slowly progressive IDDM
16. Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency
17. Glutamic acid decarboxylase antibody levels predict rate of B-cell decline in adult-onset diabetes
18. GAD antibodies in NIDDM
19. UKPDS 25:autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
20. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies
21. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes
22. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bdc/IA-2 autoantibodies
23. Controversies on humoral immune markers of insulin-dependent diabetes mellitus
24. Autoantibodies to GABA-ergic neurons and pancreatic β cells in stiff-man syndrome
25. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with APECED (autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy)
26. Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients-at diagnosis and following treatment
27. Immunoglobulin variable gene analysis of human autoantibodies reveals antigen-driven immune response to glutamate decarboxylase in type 1 diabetes mellitus
28. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase
29. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes
30. Two distinct glutamic acid decarboxylase autoantibody specificities in IDDM target different epitopes
31. Glutamic acid decarboxylase autoantibodies in Stiff-Man Syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition
32. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM
33. GAD autoantibodies in IDDM, Stiff-Man Syndrome and autoimmune polyendocrine syndrome type I recognize different epitopes
34. Identification of a dominant epitope of glutamic acid decarboxylase (GAD65) recognized by autoantibodies in Stiff-Man Syndrome
35. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes
36. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes
37. 3H recombinant human ligands
38. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10
39. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM
40. High levels of concordance between assays for glutamic acid decarboxylase autoantibodies: The first international glutamic acid decarboxylase antibody workshop
41. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second international GADAb workshop
42. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop
43. Cloning, characterization and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus (IDDM)
44. Association of GAD-65, but not of GAD-67, with the Golgi complex of transfected Chinese hamster ovary cells mediated by the N-terminal region
45. Differential detection of rat islet and brain glutamic acid decarboxylase (GAD) isoforms with sequence-specific peptide antibodies